Left panels: Higher concentrations of PCBs and OCPs in HDL from subjects with CVD and cancer than healthy controls. Upper right panel: Enrichment of highly chlorinated PCB congeners in HDL. Lower right panel: Less activity of the HDL anti-oxidant enzyme PON1 in subjects with high PCB concentrations than in subjects with low PCB concentrations.
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Introduction
Persistent organic pollutants (POPs) are a heterogeneous group of man-made chemicals, with a long half-life, that accumulate in fat tissues due to their lipophilic nature. POPs, as defined by the Stockholm Convention, hosted by the United Nations Environment Programme (www.unep.org), include polychlorinated biphenyls (PCBs), dioxins, organochlorine pesticides (OCPs) as well as polybrominated diphenyl ethers (PBDEs) (Wikoff et al 2012) . Several studies have found associations between increased serum or plasma concentrations of POPs and an increased risk for negative health effects in the general population, including cardiovascular disease (CVD) Sergeev and Carpenter 2010) , diabetes (Faerch et al. 2012; Lee et al. 2011 ) and cancer (Engel et al. 2007; Hardell et al. 2006) . The causal association between POPs and cancer has however been questioned (Golden and Kimbrough 2009 ). In addition, some studies show that people living in industrial contaminated areas have higher concentrations of POPs in plasma compared to control populations (Hovander et al. 2006) and that people consuming locally produced food in contaminated areas have higher concentrations of POPs compared to people consuming locally produced food in non-contaminated areas (Donato et al. 2006; Langer et al. 2007 ).
Although banned for more than thirty years, PCBs still persist in the environment and in food sources such as fish, meat and dairy products (Diamond et al. 2010) . The 209 different PCB congeners can either be coplanar or non-coplanar, depending on the positions of the chlorine atoms. The coplanar congeners resemble dioxins and these dioxin-like PCBs have been shown to activate the aryl hydrocarbon receptor (AhR) (Henry and DeVito 2003) . The AhR affects different signaling pathways including the retinoic acid receptor, the estrogen receptor and nuclear factor κB and may also have a role in the regulation of T-cell differentiation (Quintana 2013) . The toxicity of the non-dioxin like PCBs is poorly understood but believed to be mediated through non-AhR mechanisms. In vitro, these PCBs have been shown to antagonize androgen receptor activation, affect estrogen receptor activation, inhibit gap junction communication and bind to transthyretin (Hamers et al. 2011) . Also, neuronal toxicity through the Ryanodine receptors has been described (Wayman et al. 2012) . OCPs including 1,1-bis-(4-chlorophenyl)-2,2-dichloroethene (p,p'-DDE), hexachlorobenzene (HCB) as well as the PBDEs, which are structurally similar to PCBs, are believed to be endocrine disruptors by their interference with different hormone systems (Karami-Mohajeri and Abdollahi 2011; Li et al. 2008; Vonderheide et al. 2008 ). Furthermore, negative effects of POPs may be related to induction of proinflammatory pathways (Karami-Mohajeri and Abdollahi 2011; Gauthier and Girard 2001) .
Lipoproteins consist of an outer layer of phospholipids, proteins and free cholesterol filled with triglycerides and esterified cholesterol. Lipoproteins are classified into three main fractions depending on their density; very low-density, low-density and high-density lipoproteins (VLDL, LDL and HDL respectively). VLDL is synthesized in the liver and transports lipids to peripheral tissues. LDL arises from hydrolysis of VLDL and delivers cholesterol to the cells by receptor mediated endocytosis. HDL is responsible for the reversed cholesterol transport in which excess cholesterol is transported back to the liver for excretion into bile (Brewer 2012; Rosenson et al. 2012) . High levels of LDL cholesterol (LDL-C) are considered a strong risk factor for future CVD, thereby being the rationale for cholesterol lowering therapies. HDL, on the other hand, has been shown to possess anti-inflammatory, anti-oxidative as well as anti-thrombogenic properties, which have led to the viewpoint of HDL being protective against CVD. In line, low levels of HDL cholesterol (HDL-C) is a risk factor for CVD (Barter 2011; Chapman et al. 2011) . Many HDL functions are determined by the proteins in the particles. One such important protein is paraoxonase 1 (PON1), a calciumdependent esterase associated to HDL in the circulation (Sirivarasai et al. 2007) . PON1 has been shown to provide HDL with anti-inflammatory properties, which includes hydrolyzing lipid peroxides in LDL and preventing foam cell formation in the vascular wall (Gupta et al. 2009; Précourt et al. 2011 ). PON1 has also been shown to hydrolyze several metabolites of organophosphate pesticides such as paraoxon, chlorpyrifon, oxon and diazoxon (Costa et al. 2005) . Furthermore, reduced PON1 activity has been linked to CVD (Mackness et al. 2003) , diabetes mellitus (Gupta et al. 2011 ) and cancer (Elkiran et al. 2007) .
Early reports have shown that POPs can bind to lipoproteins (Becker and Gamble 1982; Maliwal and Guthrie 1982; Vomachka et al. 1983) . However, beside a previous study showing that a large fraction of POPs are associated to LDL/VLDL and HDL in healthy individuals (Norén et al. 1999) , little is known about the human lipoprotein distribution of POPs in vivo and how this relates to disease progress. The aims of the current study were 1) to assess the distribution of POPs in lipoprotein fractions and 2) to investigate if the distributions differ in healthy controls as compared to subjects with CVD or cancer and 3) to investigate whether the POP levels can influence the activity of HDL-associated PON1.
Method and Material

Study participants
Blood samples were available from participants in a previous questionnaire-based epidemiological study. All study subjects were living in an area polluted by POPs and metals from long lasting local industrial activities, as confirmed by environmental measurements by local authorities. For all individuals, information about age, gender, diseases, medication, diet, smoking, occupational exposure and other life-style factors was available (Helmfrid et al. 2012) . After exclusion of individuals with diseases other than cancer or CVD, the total number of subjects available for study was 78. Plasma samples from a subgroup (n=28) of non-smokers were used for POP measurement in lipoprotein fractions. Cancer and CVD cases were randomly selected. Cancer included subjects with hormone-related cancer, skin cancer or lymphoma. The healthy controls were selected so to represent the disease groups with respect to age and gender. Plasma samples covered the full range of sumPCB previously measured (2-10 ng/mL). Thirteen individuals had levels in the first and second quartile (2-4 ng/mL, 4 healthy, 4 with cancer and 7 with CVD) while 15 individuals had levels in the third and fourth quartile (5-10 ng/mL, 3 healthy, 4 with cancer and 8 with CVD) of the whole population. For arylesterase measurements, plasma from all 78 individuals was used. The clinical characteristics of selected samples are presented in Table 1 . The study was approved by the local ethics committee.
Lipoprotein isolation
Very low/low density lipoprotein (VLDL/LDL) and high density lipoprotein (HDL) were isolated from plasma with density ultracentrifugation as described before (Karlsson et al. 2005) . To avoid POP interaction with the centrifuge tubes, polycarbonate instead of polyallomer tubes were used. In short, plasma were mixed with a sucrose and EDTA solution and over layered with a KBr/PBS solution with the density 1.063 g/mL. Centrifugation was performed at 290 000 g at 15°C for 4h in a Beckman Coulter Ti 70.1 rotor. Lipoprotein fractions were aspirated and kept at -20°C in dark glass bottles prior to analysis of POPs.
Sample preparation and POP analysis
Concentrations of 20 POPs were analyzed by a previously described method , with minor modifications. 14 PCB congeners (#74, #99, #105, #118, #138, #153, #156, #157, #170, #180, #189, #194, #206 and #209), 1 dioxin (octachlorodibenzo-p-dioxin, OCDD), 4 OCPs (hexachlorobenzene, p,p'-DDE, cis-chlordane and trans-nonachlor) and 1 brominated flame retardant (bromodiphenylether #47, BDE#47) were investigated. Formic acid was used together with sonication to denature proteins in 0.5 mL of isolated LDL/VLDL or HDL fractions. Labeled 13 C internal standards were added to the samples before the POPs were extracted from lipoprotein fractions by solid-phase extraction (SPE) using Oasis® HLB single use cartridges (6 cm 3 /150 mg, Waters, Milford, MA, USA). The extracts were further purified with multi-layered acidified silica columns containing 56% KOH silica gel, 40% H2SO4 silica gel and activated anhydrous Na 2 SO 4 . Concentrations of POPs were analyzed using high resolution gas chromatography/high resolution mass spectrometry (HRGC-HRMS, Waters, Milford, MA, US).
Of all PCBs measured, 5 were dioxin-like and 9 were non-dioxin-like. The relative distribution of PCB congeners in the lipoprotein fractions compared to plasma was determined by the percentage proportion of a PCB congener in the lipoprotein fraction divided with the proportion in the plasma fraction. A ratio > 1 indicates a greater relative amount of the PCB congener in the lipoprotein fraction than in the plasma.
Paraoxonase-1 arylesterase activity in plasma
The level of Paraoxonase-1 (PON1) arylesterase activity in plasma samples were determined similar to a previously described method (Richter et al. 2008) . Plasma was diluted 1:40 in salt buffer (20 mM Tris-HCl, 1.0 mM CaCl 2 , pH 8.0) and 800 µL of phenyl acetate solution (3.26 mM phenyl acetate in salt buffer) were mixed with 80 µL diluted plasma. The absorbance of produced phenol was measured at 270 nm with 250 nm as background for 2 min in a DU 800 spectrophotometer (Beckman Coulter, Fullerton, CA, USA). The initial period when the reaction was linear were used for calculation of activity, expressed as U/mL, using an extinction coefficient of phenol of 1310 M -1 cm 1 . Each sample was analyzed in triplicate.
Statistical analysis
Concentrations of POPs in subsets were statistically evaluated and compared by age-adjusted main effects ANOVA and post-hoc test Bonferroni using Statistica (StatSoft, Tulsa, OK, USA). A p-value of less than 0.05 was considered significant. Multivariate covariations between POPs, diseases, arylesterase activity and other life-style variables were analyzed by principal component analysis (PCA) with the nonlinear iterative partial least squares (NIPALS) algorithm in Statistica. Principal components (PCs) with eigenvalues greater than 1 (Kaiser Method) and occurring before the first kink (elbow) in the Scree plot (Cattels criteria) were included in the PCA. Correlations between relative concentrations of PCBs in lipoprotein versus plasma and number of chlorines in the PCB congeners as well as between sumPCB and arylesterase-activity were analyzed with Spearman and Pearson Correlation in SPPS (v17, IBM, NY, USA), respectively.
Results
POP analyses in LDL/VLDL and HDL
All 14 PCB congeners and two pesticides (p,p'-DDE and trans-nonachlor) were detected in LDL/VLDL from most of the individuals (Table 2) . Likewise, most PCB congeners, p,p'-DDE and trans-nonachlor were detected in the HDL of almost all individuals, although at lower concentrations than in LDL/VLDL. Of the PCBs, only congener #74 and #99 were less commonly detected (in 40 % and 60 % of the subjects, respectively). In contrast, cischlordane was only detected in LDL/VLDL of one individual but not in HDL. OCDD and BDE#47 were not detected in either lipoprotein fraction in any individual. HCB was detected in LDL/VLDL (two of the controls, 7 subjects with cancer, and 12 subjects with CVD) and to a lower degree in HDL (1 control, 2 with cancer, 4 with CVD). The four non-dioxin-like PCB congeners PCB#138, PCB#153, PCB#170 and PCB#180 constituted approximately 80% of the total PCB concentration in both lipoprotein fractions.
As shown in Figure 1 , the sumPCB concentrations were significantly higher in the cancer and CVD groups compared to the healthy controls. Overall, the concentrations of PCB congeners, p,p'-DDE and trans-nonachlor were about two-fold higher in the subjects with cancer or CVD compared to healthy individuals (Table 2) . When compared to controls, subjects with cancer had significantly higher concentrations of PCB#153, PCB#170, PCB#180, PCB#209 in LDL/VLDL whereas PCB#156, PCB#153 and PCB#209 were significantly higher in HDL. Individuals with CVD showed significantly higher concentrations of PCB#156, PCB#157, PCB#180, PCB#206 in LDL/VLDL compared to controls. In HDL, PCB#138 and PCB#153 were significantly higher compared to the controls. For the OCPs, only trans-nonachlor in LDL/VLDL from subjects with CVD was significantly higher compared to healthy controls. In comparison, the original plasma analysis showed no significant differences in the concentrations of individual POPs or sumPCB between the groups although there was a similar trend towards higher concentrations in subjects with cancer and CVD than controls (supplemental table 1).
The relative distribution of PCBs in lipoproteins increased, compared to plasma, with a higher number of chlorine substitutions (Figure 2 ). In line, a correlation was observed between the number of chlorine substitutions of the congeners studied and the relative distribution in LDL/VLDL and in HDL, (r=0.64; p<0.001 and r=0.61; p<0001, respectively).
PCA showed that POP concentrations in LDL/VLDL were more associated with cancer whereas POPs in HDL were more associated with CVD ( Figure 3 ). As also shown in the PCA plot, the concentrations of POPs in both lipoprotein fractions were associated with age and female gender. In the analyses, two principal components were retained, explaining 58 % of the original variance.
Paraoxonase 1 (PON1) activity
No significant differences were found in levels of arylesterase activity in subjects with cancer and/or CVD as compared to healthy controls. However, in the larger sample (n=78) there was significant lower arylesterase activity in individuals with highest sumPCB concentrations in plasma (fourth quartile) as compared to the subjects with lowest sumPCB concentrations (first quartile); 51.8 ± 16.0 vs 73.1 ± 17.8 U/mL (p<0.001 after adjustment for smoking and age). Although less clear, also the second and third quartile showed lower activity (60.3 ± 14.2 and 70.8 ± 17.5 U/mL, respectively) compared to the first quartile and there was a negative trend between the sumPCB quartiles and arylesterase activity, r=-0.338 (p<0.01). Examining the subgroups, a significant negative correlation between sumPCB and PON1 activity were found in subjects with CVD (Figure 4 ), but not in subjects with cancer or in healthy individuals. In concordance, an association between decreased arylesterase activity, increased concentration of sumPCB in plasma and CVD was also seen in the PCA ( Figure 5 ). In the analyses, two principal components were retained, explaining 30 % of the original variance.
Discussion
In the present study we show that plasma lipoprotein fractions in subjects with reported CVD or cancer contain higher concentrations of POPs compared to healthy individuals living in the same area. Interestingly, multivariate analysis indicated that high POP concentrations in HDL were more associated to CVD while high POP concentrations in LDL/VLDL were more associated to cancer. These observations suggest that the biological relevance of the binding of POPs to lipoprotein particles is more complex than merely a distribution of the lipophilic POPs to the cholesterol particles from the surrounding hydrophilic milieu in the blood. Therefore, it is likely that HDL and LDL are important routes for the distribution of these toxic compounds in the body that needs to be considered. At the same time, it is important to point out that this cross-sectional study does not allow conclusions regarding causality and we cannot exclude that the diseases or medications may affect the concentrations of POPs. However, no significant differences in POP concentrations were found when comparing the individuals with cancer that received cytostatic treatment with those that did not or when comparing individuals with CVD treated with anticoagulants, antihypertensive drugs and/or statins to subjects with CVD not receiving these drugs. Due to the low number of subjects, no analysis of subgroups, e.g. specific cancer types, was performed. Notably, four of the eight cases had hormone-related cancers that are suspected to be associated with POP exposure.
Fourteen PCB congeners and 3 pesticides were detected in HDL and LDL/VLDL. The concentrations were about three times higher in LDL/VLDL compared to HDL, consistent with previous results (Norén et al. 1999 ). In line with plasma analyses (Faerch et al. 2012; Lind et al. 2012) , the non-dioxin-like congeners PCB#138, PCB#153, PCB#170 and PCB#180 were found in the highest concentrations. However, compared to plasma, we found an enrichment of highly chlorinated PCBs, octa-, nona-and deca-chlorinated PCBs, in the lipoprotein fractions. Interestingly, the same congeners (PCB#194, #206 and #209) have recently been shown to be associated with the presence of echolucent intima-media complex , which is a marker for a lipid-rich arterial wall and a suggested predictor for future CVD mortality (Wohlin et al. 2009 ).
In the multivariate model used (PCA with NIPALS algorithm) we included the factors age, POP concentrations of investigated fractions, sample groups and clinical parameters such as triglycerides and cholesterol. The model aims at simplifying complex datasets by creating principal components based on the variation of the input variables. These are then used to visualize and find systematic variations and how these relate to each other. The loading plot showed that the POP concentrations grouped together in two clusters indicating high levels of covariation. Interestingly, POPs in HDL were located relatively close to the CVD patients indicating a covariation between these variables, while POPs in LDL showed an association with the cancer group. These results indicate a link between POPs in HDL and CVD as well as between POPs in LDL and cancer. Such associations might be potentially important to understand why CVD and cancer are related to increased plasma concentrations of POPs (Engel et al. 2007; Hardell et al. 2006; Lind et al. 2012; Sergeev & Carpenter 2010) . In general, HDL is believed to have a protective role in CVD partly mediated through the reversed cholesterol transport in which HDL deliver excess cholesterol to the hepatocytes for further excretion. Through this action, HDL may participate in the clearance of POPs from the circulation. Besides, HDL probably has an important anti-inflammatory action in the circulation and the arterial wall through the anti-oxidant enzyme PON1 located on the HDL particle. In rats exposed to the dioxin-like congener PCB-126, increased expression and activity of PON1 have been described (Shen et al. 2012) . In the present study, we found an inverse correlation between the sum of PCBs and PON1 activity in plasma among the subjects with CVD. These results indicate that PCBs may affect the activity of PON1 in HDL. Reduced PON1 activity is a described risk factor for CVD (Mackness et al. 2003) and may diminish the ability of HDL to neutralize oxidized products, such as oxidized LDL, in the vascular wall and increase the risk of atherosclerosis. Contrary to HDL, LDL delivers cholesterol to peripheral cells. Therefore, a transfer route of POPs via LDL-receptor mediated endocytosis is possible. Notably, tumor cells have an increased need for structural elements and are thereby known to up-regulate LDL receptors (Pires et al. 2012) . These mechanisms may result in increased LDL-POP transport into the tumor cells. On the other hand, an in vitro study has suggested that LDL-receptors play a minor role in the cellular uptake of DDTlipoprotein complexes (Hjelmborg et al. 2008) . Since POPs have been described to be carcinogenic (National Toxicology Program 2006), affecting gene expression (Mitra et al. 2012) , be pro-inflammatory (Kim et al. 2012) and to cause oxidative stress (Abdollahi et al. 2004) , they may, once inside the cells, contribute to the initiation of tumors as well as tumor progression. It is also possible that POPs may alter LDL function through effects on apolipoproteins (Arehart et al. 2004) . Further studies are therefore needed to investigate the protein composition of both LDL and HDL in relation to POPs.
In conclusion, 14 PCB congeners and 3 pesticides were analyzed in HDL and LDL, and higher concentrations of POPs were found in lipoprotein fractions from individuals with CVD or cancer compared to healthy controls. We also found a negative correlation between PON1 arylesterase activity and the concentrations of PCB in plasma. These findings support the hypothesis that POPs are transported in the lipoprotein fractions and indicate that PCB can affect the HDL anti-oxidative function. 27.0 ± 3.9 25.9 ± 4.8 27.4 ± 4.4 27.6 ± 3.9 Triglycerides mmol/L (mean ± SD)
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